Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype

American Journal of Pathology

Volumn 160, Issue 6, 2002, Pages 2207-2217

  Park, David S ^a,b   Woodman, Scott E ^a,b   Schubert, William ^a,b   Cohen, Alex W ^a,b   Frank, Philippe G ^a,b   Chandra, Madhulika ^a   Shirani, Jamshid ^a   Razani, Babak ^a,b   Tang, Baiyu ^a   Jelicks, Linda A ^a   Factor, Stephen M ^a   Weiss, Louis M ^a   Tanowitz, Herbert B ^a   Lisanti, Michael P ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b ALBERT EINSTEIN CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CAVEOLIN 1; CAVEOLIN 3; GENE PRODUCT;

ADIPOCYTE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CAVEOLA; CELL TYPE; CELLULAR DISTRIBUTION; ENDOTHELIUM CELL; FERTILITY; HEART HYPERTROPHY; HEART LEFT VENTRICLE WALL; HEART MUSCLE CELL; KNOCKOUT MOUSE; MOUSE; MULTIGENE FAMILY; NONHUMAN; NORTHERN BLOTTING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; SKELETAL MUSCLE; SMOOTH MUSCLE FIBER;

EID: 0036080902     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61168-6     Document Type: Article

References (55)

1. Caveolin-deficient mice: Insights into caveolar function and human disease
2. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family
3. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells: Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated grycoproteins
4. Role of caveolae and caveolin-3 in muscular dystrophy
5. Emerging themes in lipid rafts and caveolae
6. Oligomeric structure of caveolin: Implications for caveolae membrane organization
7. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle
8. Expression of caveolin-1 is required for the transport of caveolin-2 to the plasma membrane: Retention of caveolin-2 at the level of the Golgi complex
9. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities
10. Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo
11. Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation
12. Caveolin, cholesterol, and lipid droplets?
13. p42/44 MAP kinase-dependent and -independent signaling pathways regulate caveolin-1 gene expression
14. Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling
15. Caveolin-1 regulates transforming growth factor (TGF)-β/SMAD signaling through an interaction with the TGF-β type I receptor
16. Reciprocal regulation of Neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for mammary tumorigenesis
17. Invasion activating caveolin-1 mutation in human scirrhous breast cancers
18. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy
19. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice
20. Caveolin-1 deficient mice are lean, resistant to diet-induced obesity, and show hyper-triglyceridemia with adipocyte abnormalities
21. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and T-tubule abnormalities
22. Caveolin-3 deficiency causes muscle degeneration in mice
23. Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis
24. Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution: Identification and epitope mapping of an isoform-specific monoclonal antibody probe
25. Cell-type and tissue-specific expression of caveolin-2: Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo
26. The fine structure of the gall bladder epithelium of the mouse
27. Junctional complexes in various epithelia
28. Cardioprotective effects of verapamil on myocardial structure and function in a murine model of chronic Trypanosoma cruzi infection (Brazil Strain): An echocardiographic study
29. Two-dimensional echocardiographic determination of left ventricular volume, systolic function, and mass: Summary and discussion of the 1989 recommendations of the American Society of Echocardiography
30. New approaches to phenotypic analysis in adult mice
31. Caveolin, a protein component of caveolae membrane coats
32. Caveolins, liquid-ordered domains, and signal transduction
33. Signaling pathways for cardiac hypertrophy and failure
34. Down-regulation of caveolin by chronic β-adrenergic receptor stimulation in mice
35. Decreased expression of myocardial eNOS and caveolin in dogs with hypertrophic cardiomyopathy
36. Evidence for a regulated, interaction between hetero-trimeric G proteins and caveolin
37. Src tyrosine kinases, G α subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin: Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases
38. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains: Detergent-free purification of caveolae membranes
39. Accumulation of molecules involved in α1-adrenergic signal within caveolae: Caveolin expression and the development of cardiac hypertrophy
40. Adverse effects of chronic endogenous sympathetic drive induced by cardiac GS α overexpression
41. Apoptosis of cardiac myocytes in Gsa transgenic mice
42. Myocardial Gi α-protein levels in patients with hypertensive cardiac hypertrophy, ischemic heart disease, and cardiogenic shock
43. Targeting gene expression to specific cardiovascular cell types in transgenic mice
44. Targeted down-regulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade
45. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth
46. Involvement of caveolin-1 in meiotic cell-cycle progression in Caenorhabditis elegans
47. Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts: Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formation
48. Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy
49. Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency
50. Nitric oxide synthases and cardiac muscle: Autocrine and paracrine influences
51. Factors released from endocardium of the ferret and pig modulate myocardial contraction
52. Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro: Implications for the development of heart failure
53. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes
54. Modulation of the endothelial nitric-oxide synthase-caveolin interaction in cardiac myocytes: Implications for the autonomic regulation of heart rate